Zoetis (NYSE:ZTS) Shares Unloaded Sen. Markwayne Mullin

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Zoetis Inc. (NYSE:ZTS). In a filing disclosed on December 05th, the Senator disclosed that they had sold between $15,001 and $50,000 in Zoetis stock on November 10th.

Senator Markwayne Mullin also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of CSX (NASDAQ:CSX) on 11/10/2025.
• Purchased $50,001 – $100,000 in shares of Capital One Financial (NYSE:COF) on 11/10/2025.
• Purchased $15,001 – $50,000 in shares of Pentair (NYSE:PNR) on 11/10/2025.
• Sold $15,001 – $50,000 in shares of Berkshire Hathaway (NYSE:BRK.B) on 11/3/2025.
• Sold $50,001 – $100,000 in shares of T-Mobile US (NASDAQ:TMUS) on 11/3/2025.
• Sold $15,001 – $50,000 in shares of (NASDAQ:FI) on 11/3/2025.
• Purchased $250,001 – $500,000 in shares of Microsoft (NASDAQ:MSFT) on 11/3/2025.
• Sold $15,001 – $50,000 in shares of Chipotle Mexican Grill (NYSE:CMG) on 11/3/2025.
• Purchased $50,001 – $100,000 in shares of Intuitive Surgical (NASDAQ:ISRG) on 9/24/2025.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 9/24/2025.

Zoetis Price Performance

ZTS stock opened at $118.69 on Friday. The firm has a 50 day simple moving average of $133.77 and a two-hundred day simple moving average of $147.78. The stock has a market cap of $52.31 billion, a PE ratio of 19.98, a P/E/G ratio of 2.50 and a beta of 0.97. Zoetis Inc. has a one year low of $115.25 and a one year high of $181.85. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the prior year, the company earned $1.58 EPS. The firm’s revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Friday, October 31st. Zoetis’s dividend payout ratio is currently 33.67%.

Institutional Investors Weigh In On Zoetis

Several hedge funds and other institutional investors have recently made changes to their positions in ZTS. Swiss Life Asset Management Ltd boosted its position in shares of Zoetis by 11.3% in the third quarter. Swiss Life Asset Management Ltd now owns 145,691 shares of the company’s stock worth $21,318,000 after purchasing an additional 14,744 shares during the period. Tevis Investment Management lifted its stake in shares of Zoetis by 5.8% during the 3rd quarter. Tevis Investment Management now owns 3,054 shares of the company’s stock valued at $447,000 after buying an additional 167 shares in the last quarter. Groupama Asset Managment lifted its stake in shares of Zoetis by 19.5% during the 3rd quarter. Groupama Asset Managment now owns 8,551 shares of the company’s stock valued at $1,251,000 after buying an additional 1,394 shares in the last quarter. Investment Research Partners LLC bought a new position in Zoetis in the 3rd quarter worth $386,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in Zoetis in the 3rd quarter worth $31,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on ZTS. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Piper Sandler lifted their price objective on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. KeyCorp began coverage on Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating for the company. Stifel Nicolaus dropped their price target on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a report on Tuesday, November 18th. Finally, UBS Group reduced their price target on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $178.89.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.